{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:06:46Z","timestamp":1768640806005,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.drugalcdep.2011.10.004","type":"journal-article","created":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T20:21:01Z","timestamp":1322079661000},"page":"241-246","source":"Crossref","is-referenced-by-count":58,"title":["Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors"],"prefix":"10.1016","volume":"122","author":[{"given":"Elizabeth M.","family":"Oliva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex H.S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie A.","family":"Trafton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11606-006-0023-1","article-title":"Treating homeless opioid dependent patients with buprenorphine in an office-based setting","volume":"22","author":"Alford","year":"2007","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1995"},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0015","unstructured":"American Psychiatric Association, 2010. APA Announces Draft Diagnostic Criteria for DSM-5: New Proposed Changes Posted for Leading Manual of Mental Disorders. American Psychiatric Association, Arlington, VA. Retrieved March 22, 2011, from http:\/\/www.dsm5.org\/Newsroom\/Documents\/Diag%20%20Criteria%20General% 20FINAL%202.05.pdf."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0020","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1360-0443.2009.02539.x","article-title":"Comparison of costs and utilization among buprenorphine and methadone patients","volume":"104","author":"Barnett","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1360-0443.2009.02627.x","article-title":"Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0030","doi-asserted-by":"crossref","first-page":"c5475","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database","volume":"341","author":"Cornish","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0035","unstructured":"Department of Veterans Affairs, 2009. Veterans Health Administration. Uniform Mental Health Services in VA Medical Centers and Clinics. http:\/\/www1.va.gov\/vhapublications\/ViewPublication.asp?pub_ID=1762 (accessed on 23.03.09)."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/10550490701860971","article-title":"Long-term treatment with buprenorphine\/naloxone in primary care: results at 2\u20135 years","volume":"17","author":"Fiellin","year":"2008","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0050","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0055","unstructured":"Goodman, F., Gordon, A., Kivlahan, D., Dalack, G., McNicholas, L., Oslin, D., Saxon, A., Suchinsky, R., for the VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel, 2007. Criteria for use of buprenophine\/naloxone and Buprenorphine sublingual tablets. http:\/\/www.pbm.va.gov\/Clinical%20Guidance\/Criteria%20For%20Use\/Buprenorphine,%20Criteria%20for%20Formulary%20Use.pdf (accessed on 04.11.11)."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/a0022776","article-title":"Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration","volume":"25","author":"Gordon","year":"2011","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.drugalcdep.2007.03.010","article-title":"Implementation of buprenorphine in the Veterans Health Administration: results of the first 3 years","volume":"90","author":"Gordon","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00019053-200523010-00007","article-title":"A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting","volume":"23","author":"Harris","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2008.07.013","article-title":"Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients","volume":"99","author":"Jones","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J069v18n02_02","article-title":"Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment","volume":"18","author":"Lewis","year":"1999","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0085","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0090","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0095","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"Effective medical treatment of opiate addiction","volume":"280","author":"National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.drugalcdep.2011.10.004_bib0120","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11920-011-0222-2","article-title":"Barriers to use of pharmacotherapy for addiction disorders and how to overcome them","volume":"13","author":"Oliva","year":"2011","journal-title":"Curr. Psychiatry Reports"},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2009.07.013","article-title":"Long-term outcomes of office-based buprenorphine\/naloxone maintenance therapy","volume":"106","author":"Parran","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0110","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2011.10.004_bib0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsat.2007.08.004","article-title":"Buprenorphine\/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors","volume":"35","author":"Sullivan","year":"2008","journal-title":"J. Subst. Abuse Treat."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161100439X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161100439X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T02:56:01Z","timestamp":1543373761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161100439X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S037687161100439X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.10.004","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}